OnLume announced recently that it is beginning a clinical trial for its fluorescence-guided surgery (FGS) imaging device, which will be combined with a novel nerve-targeting agent. The Phase I-II study, which…

OnLume, a medical device company developing surgical lighting technology, is the recipient of a Phase I SBIR grant through the National Cancer Institute SBIR worth $300,000. “At OnLume, we believe…